Cargando…
Efficiency of anti‐VEGF therapy in central nervous system AML relapse: A case report and literature review
There have been few reports on the treatment of central nervous system (CNS) acute myeloid leukemia (AML) relapse. This case study demonstrates that bevacizumab may be a viable treatment option when combined with IT chemotherapy as maintenance therapy for those with CNS leukemia.
Autores principales: | Cao, Han‐Yu, Tao, Tao, Shen, Xiang‐Dong, Bai, Lian, Wan, Chao‐Ling, Wu, De‐Pei, Li, Jin‐Li, Xue, Sheng‐Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813665/ https://www.ncbi.nlm.nih.gov/pubmed/35140963 http://dx.doi.org/10.1002/ccr3.5367 |
Ejemplares similares
-
Relapsed Primary Central Nervous System Lymphoma: Current Advances
por: Tao, Kaiyan, et al.
Publicado: (2021) -
Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report
por: Ma, Shuang, et al.
Publicado: (2018) -
Multiple myeloma with central nervous system relapse
por: Egan, Philip A., et al.
Publicado: (2020) -
Primary central nervous system histiocytic sarcoma: A case report and review of literature
por: Ma, Shuang, et al.
Publicado: (2018) -
Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF gene
por: Li, Li, et al.
Publicado: (2017)